REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Nefrologico Del Choco S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Instituto Nefrologico Del Choco S.A.S Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Nefrologico Del Choco S.A.S is an enterprise in Colombia, with the main office in Quibdo. The enterprise currently operates in the Ambulatory Health Care Services sector. It was established on October 18, 2011. 2 (2019) employees currently work for Instituto Nefrologico Del Choco S.A.S. In its most recent financial highlights, the company reported a net sales revenue increase of 30.07% in 2023. Its total assets grew by 15.34% over the same period. In 2023, Instituto Nefrologico Del Choco S.A.S’s net profit margin increased by 0.1%.

Headquarters
Carrera 3 29 52 Piso 5
Quibdo; Choco; Postal Code: 0207

Contact Details: Purchase the Instituto Nefrologico Del Choco S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Nefrologico Del Choco S.A.S report to view the information.
Outstanding Shares:
Purchase the Instituto Nefrologico Del Choco S.A.S report to view the information.
Incorporation Date:
October 18, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Nefrologico Del Choco S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
30.07%
Total operating revenue
30.07%
Operating profit (EBIT)
-9.11%
EBITDA
-14.14%
Net Profit (Loss) for the Period
31.69%
Total assets
15.34%
Total equity
36.66%
Operating Profit Margin (ROS)
-7.08%
Net Profit Margin
0.1%
Return on Equity (ROE)
-1.03%
Debt to Equity Ratio
-0.19%
Quick Ratio
0.07%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?